Nationality Danish Occupation CEO, Shire plc | Name Flemming Ornskov | |
![]() | ||
Alma mater University of CopenhagenINSEADHarvard University Salary US$4,137,000 (total compensation, 2014) |
Shire ceo flemming ornskov md
Flemming Ørnskov is a Danish businessman who has been the chief executive officer (CEO) of Shire plc, a FTSE 100 speciality biopharmaceutical company since 30 April 2013, succeeding Angus Russell. He previously worked for Bayer.

Ornskov received his MD from the University of Copenhagen, followed by an MBA from INSEAD, and a Master of Public Health (MPH) from Harvard University.




References
Flemming Ørnskov Wikipedia(Text) CC BY-SA